Yes it is great to see this trial finally underway. I have to say I was surprised how quickly the first patient was recruited and treated. The dose escalation stage of trials like this are often slow to recruit as doctors and patients know that the treatment is not yet at the optimal level.
All of this is a good sign that the recruitment will be faster than planned, but of course it will ultimately depend on the what results are seen in the clinic. Onwards and upwards.
Ann: First Patient Dosed in Phase 1b/2 AML Trial, page-16
-
- There are more pages in this discussion • 230 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |